Immunohistochemical detection of complement factors: a reliable method for the diagnosis of myasthenia gravis

被引:0
|
作者
Zander, T
Schwab, S
Laufenberg, I
Sieb, JP
机构
[1] Univ Bonn, Neurol Kliniken, D-5300 Bonn, Germany
[2] Heidelberg Univ, Neurol Kliniken, D-6900 Heidelberg, Germany
来源
NERVENARZT | 2000年 / 71卷 / 08期
关键词
myasthenia gravis; diagnosis; complement; neuromuscular junction;
D O I
10.1007/s001150050644
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
A 57-year-old woman suffered from generalized muscular weakness without diplopia or dysphagia for about 2 years. An abnormal decremental response on low frequency nerve stimulation and improvement upon administration of edrophonium chloride suggested a diagnosis of myasthenia gravis. However,this diagnosis remained uncertain, since repeated tests for antiacetylcholine receptor antibodies were negative. In addition, the patient reported that she was never able to keep up with peers in prolonged physical activities since childhood. For this reason, a congenital myasthenic syndrome was suspected and an intercostal muscle biopsy performed for special end-plate studies. Immunohistochemistry of the muscle biopsy revealed membrane attack complex deposits at the end-plates. This finding definitely confirmed the diagnosis of autoimmune myasthenia gravis. In conclusion, immunohistochemistry for complement deposits at the end-plates is a simple and reliable method of confirming the diagnosis of myasthenia gravis in uncertain cases.
引用
收藏
页码:666 / 669
页数:4
相关论文
共 50 条
  • [41] An update on laboratory diagnosis in myasthenia gravis
    Oger, Joel
    Frykman, Hans
    CLINICA CHIMICA ACTA, 2015, 449 : 43 - 48
  • [42] An update on laboratory diagnosis in myasthenia gravis
    Oger, Joel
    Frykman, Hans
    CLINICA CHIMICA ACTA, 2015, 444 : 126 - 131
  • [43] Complement C2 siRNA mediated therapy of myasthenia gravis in mice
    Huda, Ruksana
    Tuzun, Erdem
    Christadoss, Premkumar
    JOURNAL OF AUTOIMMUNITY, 2013, 42 : 94 - 104
  • [44] Genetic factors in autoimmune myasthenia gravis
    Giraud, Matthieu
    Vandiedonck, Claire
    Garchon, Henri Jean
    MYASTHENIA GRAVIS AND RELATED DISORDERS: 11TH INTERNATIONAL CONFERENCE, 2008, 1132 : 180 - 192
  • [45] Visualization and characterization of complement activation in acetylcholine receptor antibody seropositive myasthenia gravis
    Huang, Yu-Fang
    Sandholm, Kerstin
    Persson, Barbro
    Nilsson, Bo
    Punga, Anna Rostedt
    MUSCLE & NERVE, 2024, 70 (04) : 851 - 861
  • [46] A Neurologist's Perspective on Understanding Myasthenia Gravis Clinical Perspectives of Etiologic Factors, Diagnosis, and Preoperative Treatment
    Mukharesh, Loulwah
    Kaminski, Henry J.
    THORACIC SURGERY CLINICS, 2019, 29 (02) : 133 - +
  • [47] ACCURACY OF THE ICE TEST IN THE DIAGNOSIS OF MYASTHENIA GRAVIS IN PATIENTS WITH PTOSIS
    Fakiri, M. Omeed
    Tavy, Denes L. J.
    Hama-Amin, Ako Dara
    Wirtz, Paul W.
    MUSCLE & NERVE, 2013, 48 (06) : 902 - 904
  • [48] Complement Inhibition in Myasthenia Gravis and Neuromyelitis Optica Spectrum Disorder
    Dodig, Dubravka
    Genge, Angela
    Selchen, Daniel
    Freedman, Mark S.
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 2023, 50 (02) : 165 - 173
  • [49] Molecular profiling of thymoma with myasthenia gravis: Risk factors of developing myasthenia gravis in thymoma patients
    Lee, Ming-Ching
    Hsiao, Tzu-Hung
    Chuang, Han-Ni
    Lee, Li-Wen
    Chi, Pei-Ling
    Tsai, Hui-Mei
    Mao, Chien-Lin
    Hsu, Chung-Ping
    LUNG CANCER, 2020, 139 : 157 - 164
  • [50] Italian recommendations for the diagnosis and treatment of myasthenia gravis
    Amelia Evoli
    Giovanni Antonini
    Carlo Antozzi
    Antonio DiMuzio
    Francesco Habetswallner
    Cesare Iani
    Maurizio Inghilleri
    Rocco Liguori
    Renato Mantegazza
    Roberto Massa
    Elena Pegoraro
    Roberta Ricciardi
    Carmelo Rodolico
    Neurological Sciences, 2019, 40 : 1111 - 1124